Dudediligence.

Boston Scientific Corporation

BSXNYSE · Surgical & Medical Instruments & Apparatus
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$4.21BSep ’24$4.56BDec ’24$4.66BMar ’25$5.06BJun ’25$5.07BSep ’25$5.29BDec ’25$5.20BMar ’26$5.44BJun ’26
Net income, by quarter
$468.0MSep ’24$562.0MDec ’24$672.0MMar ’25$795.0MJun ’25$755.0MSep ’25$670.0MDec ’25$1.34BMar ’26$905.0MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$11.89B$12.68B$14.24B$16.75B$20.07B
Gross profit$8.18B$8.73B$9.90B$11.49B$13.85B
Operating income$1.20B$1.65B$2.34B$2.60B$3.61B
Net income$1.04B$698.0M$1.59B$1.85B$2.89B
Operating cash flow$1.87B$1.53B$2.50B$3.44B$4.53B
Free cash flow$1.32B$938.0M$1.79B$2.65B$3.66B
Cash$1.93B$928.0M$865.0M$414.0M$1.97B
Debt$9.06B$8.94B$9.10B$10.75B$11.44B
Shares outstanding1.69B1.70B1.73B1.74B1.75B